Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 5Phase 1/2 5Phase NA 2Phase 3 2

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5Sarcoma 3

Conditions

Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 35Nasopharyngeal Carcinoma 19Oropharyngeal Neoplasms 17Carcinoma, Squamous Cell 15Rectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Mouth Neoplasms 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Laryngeal Neoplasms 7Sarcoma 6Tongue Neoplasms 5Papillomavirus Infections 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Glioblastoma 5Brain Neoplasms 5Stomatitis 4Neoplasm Metastasis 4Nasopharyngeal Neoplasms 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Carcinoma, Anaplastic 3Lymphatic Metastasis 3Gliosarcoma 3Glioma 3

Interventions

Temozolomide 154Bevacizumab 88Radiotherapy 75Radiation 23Magnetic Resonance Spectroscopy 23Lomustine 18Irinotecan 18pembrolizumab 17Surgical Procedures, Operative 16Carmustine 16Erlotinib Hydrochloride 12Nivolumab 11Specimen Handling 10Aminolevulinic Acid 10sargramostim 9Thalidomide 9Chemotherapy, Adjuvant 9Carboplatin 9Immunoglobulin G 7Filgrastim 7Etoposide 7Drug Therapy 7Disulfides 7Cilengitide 7Sunitinib 6Sorafenib 6O(6)-benzylguanine 6Cyclophosphamide 6antineoplaston AS 2-1 5antineoplaston A10 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all
NCT05653635 2026-02-04

ReciDOPA

Centre Paul Strauss

Phase 2 Recruiting
54 enrolled
CNS

Glioblastoma

NCT02179086 2026-01-14

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2 Active not recruiting
606 enrolled
CNS

Glioblastoma

NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01062425 2022-07-26

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 2 Completed
261 enrolled 10 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02394665 2017-01-05

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

University of Miami

Phase 2 Terminated
1 enrolled 3 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡